我国哮喘病患者可避免住院现状分析  

Analysis on Avoidable Admission of Asthma in China

作　　者：李倩[1] 江芹 周海龙 张振忠[1] LI Qian;JIANG Qin;ZHOU Hai-long(Harbin Medical University,Harbin,150086,China)

机构地区：[1]哈尔滨医科大学,哈尔滨150086 [2]国家卫生健康委卫生发展研究中心,北京100044

出　　处：《中国卫生经济》2020年第3期59-63,共5页Chinese Health Economics

基　　金：国家自然科学基金项目(71704032)。

摘　　要：目的:初步构建哮喘病可避免住院临床识别指标框架,分析我国哮喘病可避免住院患者的影响因素。方法:收集东、中、西6家不同级别医疗机构2015—2017年哮喘病患者病案首页数据,对社会人口学因素、住院费用、疾病复杂程度等指标进行影响因素分析,了解我国哮喘病患者可避免住院现状。结果:2015—2017年间,我国哮喘病患者可避免住院率达22.73%;年龄、住院费用、地区是影响哮喘病可避免住院发生的危险因素。结论:我国哮喘病可避免住院现象普遍存在,且地区、人群差异性较大,需加强政策引导,推进规范化与优质化的初级卫生服务,提高哮喘病防治与管理水平,从而降低哮喘病疾病负担。Objective:By establishing the framework of clinical identification indicator for avoidable admissions of asthma patients,to analyze the avoidable admissions and influencing factors on asthma in China.Methods:Collecting the data of inpatient medical re cords of 6 hospitals from the eastern,central and western to obtain the avoidable admission rate and analyze the influencing factors of social demographic factors,hospitalization expenses and the complexity of the disease.Results:From 2015 to 2017,avoidable admis sions rate of asthma in China was 22.73%.Age,hospitalization expense and regions are the top 3 risk factors for avoidable admissions.Conclusion:In China,the phenomenon of avoidable admission is relatively common,and difference exists in the different region and different population.It is necessary to strengthen policy guidance,promote the standardization and quality of primary healthcare servic es,strengthen the level of asthma prevention and management,so as to reduce the burden of asthma diseases.

关 键 词：哮喘病 可避免住院 住院费用 

分 类 号：R1-9[医药卫生—公共卫生与预防医学] R195.4